Skip to content
Back to Investors
TP

Twin Path

Venture Capital

Twin Path Ventures is a pre-seed venture capital fund backing technical teams bringing deep tech advances to industry.

Portfolio

12

companies

Investment by month

By category

  • Uncategorised£23.9M
  • AI/ML£12.0M
  • CleanTech£3.7M
  • SecurTech£1.5M
  • Enterprise Software£862K

By location

  • London£28.2M
  • United Kingdom£7.5M
  • Norwich£2.9M
  • Lincoln£2.0M
  • Belfast£1.3M

Portfolio companies

AD

AMPLY Discovery

AMPLY Discovery develops therapeutic programmes using artificial intelligence and experimental testing.

C

Causa

Causa provides a causal AI platform for development teams.

HotHouse Therapeutics

HotHouse Therapeutics

HotHouse Therapeutics develops sustainable pharmaceutical compounds using an AI-optimised plant-based chemistry platform.

JA

Jenesys AI

Jenesys AI builds artificial intelligence software to automate transactional accounting and B2B payments.

LeoTrace

LeoTrace

LeoTrace builds security software that intercepts and checks AI generated code.

SA

Sagittal AI

Sagittal AI builds artificial intelligence solutions that integrate into developer workflows to handle complete software tasks.

View all 12 companies

Team

John Spindler

John Spindler

Partner

John serves as a general partner at Twin Path Ventures and co-founded the London Co-Investment Fund alongside AI Seed. He brings extensive early-stage investing experience, including past roles at Capital List and Basestone.

LinkedIn
KL

Katie Lockwood

Partner

Katie brings venture capital and legal experience from roles at Twin Path Ventures and Taylor Wessing. She also advises health start-ups on business and intellectual property strategy.

LinkedIn

Recent investments

Pre-Seed
£1.5M

The round was backed by a syndicate of investors including Aligned Syndicate, Leeds Angels, and Arx Ventures.

"At the moment, models can’t verify themselves. So when a bank, for example, ships machine-written code into production, that’s on the model’s word that it’s safe."
— Patrick Rycroft, Co-founder and CEO
Seed
£2.0M

The funding round was led by Mercia Ventures to support the development of satellite protection technology and the company relocation to Lincoln.

"Much of modern life depends on space – our adversaries understand this and deliberately exploit uncertainty and delay."
— Graeme Ritchie, CEO
Pre-Seed
£730K

The pre-seed round was led by Twin Path Ventures with participation from SFC Capital and strategic angels.

"It would have taken the best part of a year, and tied up a lot of skilled researcher time, to get to the outputs WholeSum can do in minutes"
— Seamus Allison
Pre-Seed
£2.9M

The Norwich-based drug discovery startup emerged from stealth with backing from SynBioVen, Start Codon, UKI2S, Twin Path Ventures, Wren Capital, angels, and Innovate UK.

"We grow greener medicines using a platform that makes the impossible accessible. The drug discovery field desperately needs new chemical space and the vaccine field needs new adjuvants, with supply chains that work for everyone. By combining AI with plant engineering, we can reach molecules others cannot, and scale them in a way that supports global health, not just high-income markets."
— David Sheppard, CEO
Pre-Seed
$2.2M

Twin Path Ventures led the pre-seed round to accelerate the rollout of the artificial intelligence game creation platform.

"We want to empower creatives and storytellers to embrace the potential of AI-supported narrative game creation. It’s the future of gamemaking, and we’re at the forefront of making its possibilities a reality."
— Barn Cleave, CEO